share_log

JP Morgan Maintains Neutral on AnaptysBio, Lowers Price Target to $28

Moomoo 24/7 ·  Apr 1 10:06

JP Morgan analyst Anupam Rama maintains AnaptysBio (NASDAQ:ANAB) with a Neutral and lowers the price target from $30 to $28.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment